Mucormycosis of the Mandible and Tongue: A Systematic Scoping Review

• Published in: International dental journal 2024-06, Vol.74 (3), p.454-472
• Main Authors: Fakhruddin, Kausar Sadia, Matsubara, Victor Haruo, Warnakulasuriya, Saman, Tilakaratne, Wanninayake Mudiyansalage, Ngo, Hien Chi, Samaranayake, Lakshman P
• Format: Article
• Language: English
• Subjects: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents - therapeutic use; COVID-19; COVID-19 - complications; Humans; Mandible; Mandibular Diseases - diagnosis; Mandibular mucormycosis; Middle Aged; Mucormycosis; Mucormycosis - complications; Mucormycosis - diagnosis; Mucormycosis - therapy; Risk Factors; Tongue Diseases - diagnosis; Tongue Diseases - microbiology; Tongue mucormycosis
• ISSN: 0020-6539; 1875-595X
• DOI: 10.1016/j.identj.2023.11.011

Mucormycosis is a rare human infection associated with Mucorales, a group of filamentous moulds found in different environmental niches. Its oral manifestations may occur in the mandible and tongue despite being rare. We aimed to systematically review the data on clinical manifestations, risk factors, diagnostic approaches, treatment options, and outcomes of mandibular and tongue mucormycosis. An electronic search of articles published between January 1975 and November 2022 in PubMed, Web of Science, and EMBASE databases was performed. A total of 22 articles met the inclusion criteria and reported 27 cases of oral mucormycosis in total. Fourteen patients had mandibular mucormycosis signs unrelated to COVID-19 infection, 6 had SARS-CoV-2-related mandibular mucormycosis, and 6 had manifestations in the tongue. All published case reports during the COVID-19 pandemic were from India. Patient ages ranged from 4 months old to 82 years, and most patients had important comorbidities, such as blood dyscrasias related to immune deficiency and uncontrolled type 2 diabetes mellitus. The signs and symptoms of mandibular and tongue mucormycosis varied from dental pain, loose teeth, and nonhealing sockets to dysphagia and paraesthesia of the lip. Some patients also reported trismus, draining sinus tract, and facial pain. The diagnosis of oral mucormycosis was based on a combination of clinical, radiographic, and histopathologic findings by demonstrating fungal hyphae in tissue specimens. In most cases, mucormycosis was managed with systemic amphotericin B, strict glycaemic control, and aggressive surgical debridement of infected tissue, minimising the progression of the fungal infection and thus improving the survival rate. In some cases, combined antifungal therapy, antibiotic therapy, and chlorhexidine mouthwashes were used successfully. Recognition of the signs and symptoms by oral care providers is pertinent for the early diagnosis and treatment of tongue and mandibular mucormycosis, and providers should be aware of the possibility of this opportunistic fungal infection in patients with COVID-19. A multidisciplinary approach is recommended for the management of this lethal infection.